Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,188,640
-$161,692 QoQ
Shares Held
11,388
-9.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#303
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 49%
Shared 0%
None 51%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Pathstone Holdings, LLC holds $154,168,058 across 23 Diagnostics & Research names. LH ranks #13 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
73,043 | $36,620,837 | |
| 2 | DHR |
Danaher Corp /De/
|
187,560 | $35,726,427 | |
| 3 | ILMN |
Illumina, Inc.
|
73,478 | $12,919,635 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
20,623 | $10,856,771 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
15,870 | $8,404,592 | |
| 6 | GH |
Guardant Health, Inc.
|
52,568 | $7,886,776 | |
| 7 | NTRA |
Natera, Inc.
|
24,881 | $6,753,947 | |
| 8 | DGX |
Quest Diagnostics Inc
|
25,434 | $5,390,735 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,188,640 | 11,388 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,350,332 | 12,557 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,852,254 | 11,369 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,907,172 | 13,611 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,949,561 | 11,236 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,654,864 | 11,407 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,361,306 | 10,297 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $2,271,673 | 10,165 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $921,492 | 4,528 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||